Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"11,321 (6,342, 19,057)","80.1% (65.7%, 98.5%)","71.6% (57.4%, 82.4%)","16.7% (12.1%, 29.9%)","77.4% (62.7%, 98.0%)","20.0 (16.4, 24.6)","17.9 (14.3, 20.6)","4.2 (3.0, 7.5)","19.3 (15.7, 24.5)",,,,,
"(p=None, None), q=(None, None), c=0.500)","9,142 (6,205, 17,605)","88.3% (73.5%, 99.6%)","60.8% (43.1%, 76.4%)","13.0% (8.9%, 19.4%)","86.0% (69.9%, 99.5%)","22.1 (18.4, 24.9)","15.2 (10.8, 19.1)","3.3 (2.2, 4.9)","21.5 (17.5, 24.9)","-17.6% (-37.5%, 5.6%)","10.7% (1.1%, 20.4%)","-15.3% (-34.1%, -1.7%)","-19.9% (-51.1%, 2.7%)","11.6% (1.5%, 22.1%)"
"(p=None, None), q=(None, None), c=0.750)","9,133 (6,411, 15,895)","88.9% (73.0%, 99.8%)","60.1% (42.6%, 75.9%)","12.6% (8.6%, 19.4%)","86.7% (70.0%, 99.7%)","22.2 (18.2, 24.9)","15.0 (10.6, 19.0)","3.2 (2.2, 4.9)","21.7 (17.5, 24.9)","-17.0% (-41.4%, 9.6%)","11.5% (1.3%, 23.3%)","-16.3% (-34.1%, -2.1%)","-22.4% (-52.4%, -0.5%)","12.6% (1.8%, 24.7%)"
"(p=None, None), q=(None, None), c=1.000)","9,409 (6,665, 16,960)","88.8% (74.0%, 99.8%)","59.2% (41.4%, 75.3%)","12.2% (8.3%, 19.0%)","86.7% (70.9%, 99.8%)","22.2 (18.5, 25.0)","14.8 (10.4, 18.8)","3.0 (2.1, 4.7)","21.7 (17.7, 24.9)","-14.3% (-35.8%, 12.7%)","11.4% (1.4%, 22.2%)","-17.6% (-35.2%, -3.3%)","-25.3% (-51.5%, -3.6%)","12.5% (1.8%, 23.6%)"
